Psilocybin with psychological support for treatment-resistant depression: six-month follow-up RL Carhart-Harris, M Bolstridge, CMJ Day, J Rucker, R Watts, DE Erritzoe, ... Psychopharmacology 235, 399-408, 2018 | 1037 | 2018 |
Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ... JAMA psychiatry 73 (3), 292-297, 2016 | 1009 | 2016 |
Neural correlates of the LSD experience revealed by multimodal neuroimaging RL Carhart-Harris, S Muthukumaraswamy, L Roseman, M Kaelen, ... Proceedings of the National Academy of Sciences 113 (17), 4853-4858, 2016 | 970 | 2016 |
Ketamine use: a review CJA Morgan, HV Curran, ... Addiction 107 (1), 27-38, 2012 | 785 | 2012 |
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms RL Carhart-Harris, L Roseman, M Bolstridge, L Demetriou, JN Pannekoek, ... Scientific reports 7 (1), 1-11, 2017 | 626 | 2017 |
Estimating the harms of nicotine-containing products using the MCDA approach DJ Nutt, LD Phillips, D Balfour, HV Curran, M Dockrell, J Foulds, ... European addiction research 20 (5), 218-225, 2014 | 507 | 2014 |
Keep off the grass? Cannabis, cognition and addiction HV Curran, TP Freeman, C Mokrysz, DA Lewis, CJA Morgan, LH Parsons Nature Reviews Neuroscience 17 (5), 293-306, 2016 | 494 | 2016 |
Benzodiazepines, memory and mood: a review H Valerie Curran Psychopharmacology 105, 1-8, 1991 | 475 | 1991 |
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study CJA Morgan, G Schafer, TP Freeman, HV Curran The British Journal of Psychiatry 197 (4), 285-290, 2010 | 422 | 2010 |
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis CJA Morgan, HV Curran The British Journal of Psychiatry 192 (4), 306-307, 2008 | 413 | 2008 |
Mood and cognitive effects of±3, 4‐methylenedioxymethamphetamine (MDMA,‘ecstasy’): week‐end ‘high’followed by mid‐week low HV Curran, RA Travill Addiction 92 (7), 821-831, 1997 | 412 | 1997 |
Consequences of chronic ketamine self‐administration upon neurocognitive function and psychological wellbeing: a 1‐year longitudinal study CJA Morgan, L Muetzelfeldt, HV Curran Addiction 105 (1), 121-133, 2010 | 386 | 2010 |
Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers CJA Morgan, A Mofeez, B Brandner, L Bromley, HV Curran Neuropsychopharmacology 29 (1), 208-218, 2004 | 366 | 2004 |
Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later HV Curran, C Morgan Addiction 95 (4), 575-590, 2000 | 350 | 2000 |
Acute and chronic effects of ketamine upon human memory: a review CJA Morgan, HV Curran Psychopharmacology 188, 408-424, 2006 | 346 | 2006 |
Tranquillising memories: a review of the effects of benzodiazepines on human memory HV Curran Biological psychology 23 (2), 179-213, 1986 | 346 | 1986 |
Benzodiazepines: risks and benefits. A reconsideration DS Baldwin, K Aitchison, A Bateson, HV Curran, S Davies, B Leonard, ... Journal of psychopharmacology 27 (11), 967-971, 2013 | 315 | 2013 |
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms MAP Bloomfield, CJA Morgan, A Egerton, S Kapur, HV Curran, OD Howes Biological psychiatry 75 (6), 470-478, 2014 | 273 | 2014 |
Journey through the K-hole: phenomenological aspects of ketamine use L Muetzelfeldt, SK Kamboj, H Rees, J Taylor, CJA Morgan, HV Curran Drug and alcohol dependence 95 (3), 219-229, 2008 | 272 | 2008 |
Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis CJA Morgan, TP Freeman, GL Schafer, HV Curran Neuropsychopharmacology 35 (9), 1879-1885, 2010 | 265 | 2010 |